Skip to Content

UK Edition. Click here for US version.

METOCLOPRAMIDE 5MG/ML SOLUTION FOR INJECTION

Active substance(s): METOCLOPRAMIDE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
PATIENT INFORMATION LEAFLET

METOCLOPRAMIDE 5mg/ml Solution for Injection
Metoclopramide Hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START RECEIVING THIS MEDICINE.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or
pharmacist.
The product is known by name above but will be referred to as Metoclopramide Injection throughout the rest of this leaflet.
What is in this leaflet:
1. What Metoclopramide Injection is and what it is used for
2. What you need to know before you are given Metoclopramide Injection
3. How to use Metoclopramide Injection
4. Possible side effects
5. How to store Metoclopramide Injection
6. Contents of the pack and other information
1. WHAT METOCLOPRAMIDE INJECTION IS AND WHAT IT IS USED FOR
Metoclopramide Injection is an antiemetic. It contains a medicine called “metoclopramide”. It works on a part of your brain that
prevents you from feeling sick (nausea) or being sick (vomiting).
Adult population
Metoclopramide Injection is used in adults:
• to prevent nausea and vomiting that may occur after surgery
• to treat nausea and vomiting including nausea and vomiting which may occur with a migraine
• to prevent nausea and vomiting caused by radiotherapy.
Paediatric population
Metoclopramide Injection is used in children (aged 1-18 years) only if other treatment does not work or cannot be used:
• to prevent delayed nausea and vomiting that may occur after chemotherapy
• to treat nausea and vomiting that has occurred after surgery.
2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN METOCLOPRAMIDE INJECTION
Do not take Metoclopramide Injection if:
• you are allergic to Metoclopramide or any of the other ingredients of this medicine (listed in section 6)
• you are breast feeding
• you have bleeding, obstruction or a tear in your stomach or gut
• you have had a stomach or bowel operation within the previous four days
• you have or may have a rare tumour of the adrenal gland, which sits near the kidney (pheochromocytoma)
• you have ever had involuntary muscle spasms (tardive dyskinesia), when you have been treated with a medicine
• you have epilepsy
• you have Parkinson’s disease
• you are taking levodopa (a medicine for Parkinson’s disease) or dopaminergic agonists (see below “Other medicines and
Metoclopramide Injection)
• you have ever had an abnormal blood pigment levels (methaemoglobinemia) or NADH cytochrome-b5 deficiency.
Do not give Metoclopramide Injection to a child less than 1 year of age (see below “Children and adolescents”).
Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking Metoclopramide injection if:
• you have a history of abnormal heart beats (QT interval prolongation) or any other heart problems
• you have problems with the levels of salts in your blood, such as potassium, sodium and magnesium
• you are using other medicines known to affect the way your heart beats
• you have any neurological (brain) problems
• you have liver or kidney problems. The dose may be reduced (see section 3)
• pregnant or if you are breast feeding
• taking any other medicine by mouth. It is possible that metoclopramide injection may change the amount of the other
medicine that gets into your body
• taking any drugs known as serotonergic drugs, as taking these medications with metoclopramide injection can cause side
effects (such as restlessness, loss of co-ordination, fast heart beat increased body temperature)"
• suffering from porphyria (a rare inherited blood disease).
Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methaemoglobinemia),
the treatment should be immediately and permanently stopped.
Even though some of the above may appear obvious, it is important that your doctor is aware if any of them apply to you.
If you are receiving this medicine for vomiting, and if the vomiting does not stop, tell your doctor. He will want to do some tests
to find out what is the cause of your vomiting.
Do not exceed 3-month treatment because of the risk of involuntary muscle spasms.
Children and adolescents
Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults. This medicine must not be used
in children below 1 year of age because of the increased risk of the uncontrollable movements (see above “You should not be
given Metoclopramide injection if”).
Other medicines and Metoclopramide injection
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This is because
some medicines can affect the way this medicine works or this medicine can affect how other medicines work. These medicines
include the following:
• levodopa or other medicines used to treat Parkinson’s disease (see above “Do not take Metoclopramide injection if”)
• morphine derivatives (medicines used to treat severe pain)
• sedative medicines
• digoxin (medicine used to treat heart failure)
• fluoxetine and paroxetine (medicine used to treat depression)
• anticholinergics (medicines used to relieve stomach cramps or spasms)
• antidepressants (e.g. other phenothiazines, lithium)
• neuroleptic medicines (for mental illness or nausea and vomiting)
• medicines for fits (anticonvulsants)
• medicines to reduce the level of the hormone prolactin in your body (e.g. bromocriptine, cabergoline)
• any medicines used to treat mental health problems
• atovaquone (to treat pneumonia)
• pain killers such as aspirin or paracetamol or stronger pain killers called opioids
• any other drugs to treat nausea and vomiting
• mivacurium and suxamethonium (medicines used to relax muscles)
• cyclosporine (medicine used to treat certain problems with the immune system).
Metoclopramide Injection with alcohol
Alcohol should not be consumed during treatment with metoclopramide because it increases the sedative effect of
Metoclopramide Injection.
Pregnancy and breast feeding
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before
being given this medicine.
If necessary, Metoclopramide Injection may be taken during pregnancy. Your doctor will decide whether or not you should be
given this medicine.
Metoclopramide Injection is not recommended if you are breast-feeding because metoclopramide passes into breast milk and
may affect your baby.
Driving and using machines
You may feel drowsy, dizzy or have uncontrollable twitching, jerking or writhing movements and unusual muscle tone causing
distortion of the body after taking Metoclopramide Injection. This may affect your vision and also interfere with your ability to
drive and use machines.
Important information about some of the ingredients of Metoclopramide Injection
This medicine also contains:
• sodium metabisulphite which may rarely cause severe hypersensitivity reactions and bronchospasm
• less than 1 mmol sodium (salt) (23mg) per dose, i.e. is essentially “sodium free”.
3. HOW TO USE METOCLOPRAMIDE INJECTION
The medicine will normally be given to you by a doctor or a nurse. It will be given as a slow injection into a vein (over at least 3
minutes) or by injection into a muscle.
In adults patients
For the treatment of nausea and vomiting including nausea and vomiting which may occur with a migraine and for the prevention
of nausea and vomiting caused by radiotherapy: the recommended single dose is 10 mg, repeated up to 3 times daily.

PATIENT INFORMATION LEAFLET

METOCLOPRAMIDE
5mg/ml Solution for
Injection

100474/LF/021/03

Version No:
Product Name:
Pack Size:
Component:
SKU:
Market:
Production Site:
Revision No.:
Revision Date:
Revised by:

Metoclopramide Injection
10 Ampoules
Leaflet
100474
UK
B. Braun
5
24/12/2014
SMT

Dimension:
Commodity No.:
Pharma Code:
Core Spec Ref:
DCMF:
Print Colours:

596 x 210 mm
N/A
N/A
N/A
N/A
Black

Non-Print Colours:

Cutter

Tech App. Date:
Min. Font Size:

03/06/2014
8 pt

CRF:
DOA:
DOI:

AMCo.CRF.019.2013
N/A
N/A

REGULATORY AUTHORITY
APPROVAL CONFIRMATION

Confirmation that this artwork has been approved by the
appropriate market authority (if applicable, e.g. MHRA,
HPRA, etc and that Mercury Pharma have license
pproval to distribute this component for sale in the
relevant market.
Accept Artwork ....................................................................
Reject Artwork ....................................................................
Signature ............................................................................
Name ..................................................................................
Date ....................................................................................

PAGE 1 OF 2

The maximum recommended dose per day is 30 mg or 0.5 mg/kg body weight.
For the prevention of nausea and vomiting that may occur after surgery prevention: a single dose of 10mg is recommended.
All indications (paediatric patients aged 1-18 years)
The recommended dose is 0.1 to 0.15 mg/kg body weight, repeated up to 3 times daily, given by slow injection into a vein.
The maximum dose in 24 hours is 0.5 mg/kg body weight.
Dosing table
Age

Body Weight

Dose

Frequency

1-3 years

10-14 kg

1 mg

Up to 3 times daily

3-5 years

15-19 kg

2 mg

Up to 3 times daily

5-9 years

20-29 kg

2.5 mg

Up to 3 times daily

9-18 years

30-60 kg

5 mg

Up to 3 times daily

15-18 years

Over 60kg

10 mg

Up to 3 times daily

The treatment should not exceed 48 hours for treatment of nausea and vomiting that has occurred after surgery.
The treatment should not exceed 5 days for prevention of delayed nausea and vomiting that may occur after chemotherapy.
Older people
The dose may need to be reduced depending on kidney problems, liver problems and overall health.
Adults with kidney problems
Talk to your doctor if you have kidney problems. The dose should be reduced if you have moderate or severe kidney problems.
Adults with liver problems
Talk to your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.
Children and adolescents
Metoclopramide must not be used in children aged less than 1 year (see section 2).
If you are given more Metoclopramide Injection than you should
Contact your doctor or pharmacist straight away. You may experience uncontrollable movements (extrapyramidal disorders),
feel drowsy, have some troubles of consciousness, be confused, have hallucination and heart problems. You doctor may
prescribe you a treatment for these signs if necessary.
If you forget to take Metoclopramide Injection
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Metoclopramide Injection can cause side effects, although not everybody gets them.
Stop the treatment and talk straight away to your doctor, pharmacist or nurse if you experience one of the following signs while
having this medicine:
• uncontrollable movements (often involving head or neck). These may occur in children or young adults and particularly when
high doses are used. These signs usually occur at the beginning of treatment and may even occur after one single
administration. These movements will stop when treated appropriately
• high fever, high blood pressure, convulsions, sweating, production of saliva. These may be signs of a condition called
neuroleptic malignant syndrome
• itching or skin rashes, swelling of the face, lips or throat, difficulty in breathing. These may be signs of an allergic reaction,
which may be severe.
Very common (may affect more than 1 in 10 people)
• feeling drowsy.
Common (may affect up to 1 in 10 people)
• depression
• uncontrollable movements such as tics, shaking, twisting movements or muscle contracture (stiffness, rigidity)
• symptoms similar to Parkinson disease (rigidity, tremor)
• feel restless
• blood pressure decrease (particularly with intravenous route)
• diarrhoea
• feeling weak.
Uncommon (may affect up to 1 in 100 people)
• raised levels of a hormone called prolactin in the blood which may cause: milk production in men, and women who are not
breast feeding
• irregular periods
• hallucination
• decreased level of consciousness
• slow heartbeat (particularly with intravenous route)
• allergy.
Rare (may affect up to 1 in 1,000 people)
• confusional state
• convulsion (especially in patients with epilepsy).
Not known (frequency cannot be estimated from the available data)
• abnormal blood pigment levels: which may change the colour of your skin
• abnormal development of breasts (gynaecomastia)
• involuntary muscle spasms after prolonged use, particularly in elderly patients
• high fever, high blood pressure, convulsions, sweating, production of saliva. These may be signs of a condition called
neuroleptic malignant syndrome
• changes in heart beat, which may be shown on an ECG test
• cardiac arrest (particularly with injection route)
• shock (severe decrease of heart pressure) (particularly with injection route)
• fainting (particularly with intravenous route)
• allergic reaction which may be severe (particularly with intravenous route)
• very high blood pressure.
If you get any side effects talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this
leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE METOCLOPRAMIDE INJECTION
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after Exp. Date.
The expiry date refers to the last day of that month.
Do not store above 25˚C. Keep the ampoule in the outer carton in order to protect from light.
If only part of the ampoule is used, discard the remaining solution. For single use only.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Metoclopramide Injection contains
Each 2ml of Metoclopramide Injection contains metoclopramide hydrochloride equivalent to 10mg anhydrous metoclopramide
hydrochloride as the active substance.
Metoclopramide Injection also contains sodium metabisulphite (E223), sodium chloride, dilute hydrochloric acid or sodium
hydroxide in water for injections.
What Metoclopramide Injection looks like and contents of the pack
Metoclopramide Injection is a clear, colourless, sterile solution for injection, presented in 2ml clear glass ampoules. They are
packed in cardboard cartons containing 10 x 2ml ampoules.
Marketing Authorisation Holder
Mercury Pharma International Ltd., 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
Manufacturer
B. Braun Melsungen AG, Mistelweg 2, 12357 Berlin, Germany.
This leaflet was last revised in December 2014.
100474/LF/021/03

100474/LF/021/03

Version No:
Product Name:
Pack Size:
Component:
SKU:
Market:
Production Site:
Revision No.:
Revision Date:
Revised by:

Metoclopramide Injection
10 Ampoules
Leaflet
100474
UK
B. Braun
5
24/12/2014
SMT

Dimension:
Commodity No.:
Pharma Code:
Core Spec Ref:
DCMF:
Print Colours:

596 x 210 mm
N/A
N/A
N/A
N/A
Black

Non-Print Colours:

Cutter

Tech App. Date:
Min. Font Size:

03/06/2014
8 pt

CRF:
DOA:
DOI:

AMCo.CRF.019.2013
N/A
N/A

REGULATORY AUTHORITY
APPROVAL CONFIRMATION

Confirmation that this artwork has been approved by the
appropriate market authority (if applicable, e.g. MHRA,
HPRA, etc and that Mercury Pharma have license
pproval to distribute this component for sale in the
relevant market.
Accept Artwork ....................................................................
Reject Artwork ....................................................................
Signature ............................................................................
Name ..................................................................................
Date ....................................................................................

PAGE 2 OF 2

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide